| NF-κβ: a potential target in the management of vascular complications of diabetes SV Suryavanshi, YA Kulkarni Frontiers in pharmacology 8, 798, 2017 | 317 | 2017 |
| Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update R Joshi, YA Kulkarni, S Wairkar Life sciences 215, 43-56, 2018 | 203 | 2018 |
| VEGF and FGF-2: Promising targets for the treatment of respiratory disorders AP Laddha, YA Kulkarni Respiratory medicine 156, 33-46, 2019 | 143 | 2019 |
| Traditional uses, phytochemistry and pharmacology of the medicinal species of the genus Cordia (Boraginaceae) MJ Oza, YA Kulkarni Journal of Pharmacy and Pharmacology 69 (7), 755-789, 2017 | 116 | 2017 |
| Tannins and vascular complications of Diabetes: An update AP Laddha, YA Kulkarni Phytomedicine 56, 229-245, 2019 | 113 | 2019 |
| Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations P Shende, YA Kulkarni, RS Gaud, K Deshmukh, R Cavalli, F Trotta, ... Journal of pharmaceutical sciences 104 (5), 1856-1863, 2015 | 112 | 2015 |
| Neuroprotective effect of cardamom oil against aluminum induced neurotoxicity in rats ST Auti, YA Kulkarni Frontiers in neurology 10, 399, 2019 | 110 | 2019 |
| Formononetin treatment in type 2 diabetic rats reduces insulin resistance and hyperglycemia MJ Oza, YA Kulkarni Frontiers in pharmacology 9, 739, 2018 | 104 | 2018 |
| Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models N Shiva, N Sharma, YA Kulkarni, SR Mulay, AB Gaikwad Life sciences 256, 117860, 2020 | 95 | 2020 |
| Hyperglycemia to nephropathy via transforming growth factor beta M Sudamrao Garud, Y Anant Kulkarni Current diabetes reviews 10 (3), 182-189, 2014 | 81 | 2014 |
| Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol KM Adki, YA Kulkarni Life sciences 250, 117544, 2020 | 73 | 2020 |
| Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes MJ Oza, YA Kulkarni Biomedicine & Pharmacotherapy 107, 1119-1127, 2018 | 72 | 2018 |
| Formononetin attenuates kidney damage in type 2 diabetic rats MJ Oza, YA Kulkarni Life sciences 219, 109-121, 2019 | 61 | 2019 |
| Gallic acid attenuates type I diabetic nephropathy in rats MS Garud, YA Kulkarni Chemico-biological interactions 282, 69-76, 2018 | 61 | 2018 |
| Diabetic nephropathy: the regulatory interplay between epigenetics and microRNAs H Sankrityayan, YA Kulkarni, AB Gaikwad Pharmacological research 141, 574-585, 2019 | 59 | 2019 |
| SIRT1-FOXOs activity regulates diabetic complications MP Jalgaonkar, UM Parmar, YA Kulkarni, MJ Oza Pharmacological Research 175, 106014, 2022 | 56 | 2022 |
| Effect of Jyotishmati (Celastrus paniculatus) seeds in animal models of pain and inflammation YA Kulkarni, S Agarwal, MS Garud Journal of Ayurveda and integrative medicine 6 (2), 82, 2015 | 52 | 2015 |
| Pharmacology of apocynin: a natural acetophenone SR Savla, AP Laddha, YA Kulkarni Drug metabolism reviews 53 (4), 542-562, 2021 | 50 | 2021 |
| ER stress response mediates diabetic microvascular complications H Sankrityayan, MJ Oza, YA Kulkarni, SR Mulay, AB Gaikwad Drug discovery today 24 (12), 2247-2257, 2019 | 47 | 2019 |
| NADPH oxidase: A membrane-bound enzyme and its inhibitors in diabetic complications AP Laddha, YA Kulkarni European journal of pharmacology 881, 173206, 2020 | 44 | 2020 |
